Handel międzynarodowy · 2.07.2026

Certain Systems, Devices, Software, Compositions, Chemicals, and Laboratory Supplies for Studying Proteins; Notice of Institution of Investigation

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on May 28, 2026, under section 337 of the Tariff Act of 1930, as amended, on behalf of Seer, Inc. of Redwood City, California and The Brigham and Women's Hospital, Inc. of Boston, Massachusetts. A supplement to the complaint was filed on June 12, 2026. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain systems, devices, software, compositions, chemicals, and laboratory supplies for studying proteins by reason of the infringement of certain claims of U.S. Patent No. 11,435,360 ("the '360 patent"); U.S. Patent No. 11,630,112 ("the '112 patent"); U.S. Patent No. 12,050,222 ("the '222 patent"); U.S. Patent No. 12,228,566 ("the '566 patent"); and U.S. Patent No. 12,590,948 ("the '948 patent"). The complaint, as supplemented, further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainants request that the Commission institute an investigation and, after the investigation, issue